Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model
/in Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenComparative impact of treatment on clinical benefit in patients with glioblastoma (GBM) enrolled in the phase II trial of ICT-107.
/in Dendritic Cells, Glioblastoma, International PublicationsDendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
/in Dendritic Cells, Glioblastoma, International PublicationsHyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling
/in Glioblastoma, Hyperthermia, International PublicationsImmune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
/in Glioblastoma, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusEXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA
/in Glioblastoma, International Publications, Newcastle Disease VirusPerspectives for immunotherapy in glioblastoma treatment
/in Dendritic Cells, Glioblastoma, International PublicationsEmerging treatment strategies for glioblastoma multiforme
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer